全文获取类型
收费全文 | 894篇 |
免费 | 43篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 25篇 |
妇产科学 | 6篇 |
基础医学 | 227篇 |
口腔科学 | 6篇 |
临床医学 | 76篇 |
内科学 | 126篇 |
皮肤病学 | 45篇 |
神经病学 | 63篇 |
特种医学 | 30篇 |
外国民族医学 | 1篇 |
外科学 | 130篇 |
综合类 | 8篇 |
预防医学 | 39篇 |
眼科学 | 15篇 |
药学 | 67篇 |
肿瘤学 | 66篇 |
出版年
2022年 | 5篇 |
2021年 | 12篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 5篇 |
2017年 | 6篇 |
2016年 | 16篇 |
2015年 | 16篇 |
2014年 | 23篇 |
2013年 | 30篇 |
2012年 | 43篇 |
2011年 | 42篇 |
2010年 | 30篇 |
2009年 | 20篇 |
2008年 | 19篇 |
2007年 | 27篇 |
2006年 | 23篇 |
2005年 | 48篇 |
2004年 | 26篇 |
2003年 | 29篇 |
2002年 | 42篇 |
2001年 | 18篇 |
2000年 | 24篇 |
1999年 | 23篇 |
1998年 | 7篇 |
1997年 | 14篇 |
1996年 | 8篇 |
1995年 | 10篇 |
1993年 | 11篇 |
1992年 | 18篇 |
1991年 | 17篇 |
1990年 | 18篇 |
1989年 | 30篇 |
1988年 | 7篇 |
1987年 | 18篇 |
1986年 | 14篇 |
1985年 | 10篇 |
1984年 | 7篇 |
1979年 | 7篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1973年 | 11篇 |
1972年 | 8篇 |
1971年 | 5篇 |
1968年 | 6篇 |
1967年 | 5篇 |
1943年 | 10篇 |
1942年 | 23篇 |
1941年 | 23篇 |
1940年 | 31篇 |
排序方式: 共有938条查询结果,搜索用时 15 毫秒
1.
2.
3.
Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy 总被引:4,自引:0,他引:4
Thorsten Kramm Balthasar Eberle Stefan Guth Eckhard Mayer 《European journal of cardio-thoracic surgery》2005,28(6):882-888
Objective: Pulmonary endarterectomy (PEA) is the standard therapy for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In the immediate postoperative period, persistent pulmonary hypertension increases the risk of acute respiratory or right heart failure. In pulmonary arterial hypertension, prostanoid inhalation has been found to improve pulmonary hemodynamics, right ventricular function, gas exchange, and clinical outcome. We report the results of a double-blinded randomized trial with the aerosolized prostacyclin analogue iloprost in patients with residual pulmonary hypertension after PEA. Methods: Twenty-two patients (age, 55 ± 13 years; 8 females; propofol- and sufentanil-based anesthesia; pressure-controlled mechanical ventilation) were randomized to receive either a single dose of 25 μg aerosolized iloprost (iloprost group; n = 11) or normal saline (placebo group; n = 11) immediately after postoperative ICU admission. Primary endpoints were changes in gas exchange, pulmonary and systemic hemodynamics, and clinical outcome. Results: Iloprost significantly enhanced cardiac index (CI) and reduced mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance [PVR (dyn s cm−5)] in contrast to placebo. Placebo: pre-inhalation 413 ± 195 versus post-inhalation 404 ± 196 at 30 min (p = 0.051), 415 ± 189 at 90 min (p = 0.929). Iloprost: pre-inhalation 503 ± 238 versus post-inhalation 328 ± 215 at 30 min (p = 0.001), 353 ± 156 at 90 min (p = 0.003). Blood oxygenation remained unchanged. Conclusion: In addition to the effect of PEA, iloprost reduces residual postoperative pulmonary hypertension, decreases right ventricular afterload and may facilitate the early postoperative management after PEA. 相似文献
4.
C Juarbe L Shemen R Wang V Anand R Eberle A Sirovatka K Malanaphy I Klatsky 《Archives of otolaryngology--head & neck surgery》1989,115(3):356-359
Tracheoesophageal puncture was performed in ten of our patients undergoing extended laryngopharyngectomy. Three fistulas were allowed to close, and two patients were dissatisfied with their results, which allowed for an overall 50% success rate in this subgroup. The resultant voice was objectively compared with similar groups of patients undergoing primary and secondary tracheoesophageal puncture after standard laryngectomy. There was no significant difference in maximum phonation time, average speaking intensity, and average fundamental frequency between these groups. However, the maximum intensity and average intensity were significantly lower for the flap group. Our results indicate that tracheoesophageal puncture should be attempted in patients undergoing the extended procedure, notwithstanding a lower expected success rate. 相似文献
5.
6.
A. Pansky F. Peng M. Eberhard L. Baselgia W. Siegrist J. B. Baumann A. N. Eberle C. Beglinger & P. Hildebrand 《European journal of clinical investigation》1996,27(1):69-76
Bombesin was originally isolated from amphibian skin, wherease its mammalian counterpart, gastrin-releasing peptide (GRP), was first identified in the nervous system of the gastrointestinal tract. Whether GRP is present in the human skin is not known. Bombesin-like peptides are also known to modulate growth. We therefore investigated whether human melanoma cell lines express functional GRP-preferring bombesin receptors and whether they alter growth or other specific cellular functions of these tumour cells. GRP receptor mRNA was found in HBL, D-10, Me-28 and A375-6 cell lines, but only A375-6 cells express a large number of high-affinity binding sites for [125 I]-[Tyr4 ] bombesin ( K d 0.31 ± 0.04 nmol L−1 , 3880 ± 429 binding sites per cell). Bombesin dose-dependently increased cytosolic calcium, but did not alter interleukin (IL) 1β-induced reduction of cell viability or IL-6 secretion, both A375-6-specific cell functions. Growth of A375-6 cells was not altered by bombesin or the specific GRP receptor antagonist BIM26226 as measured by [3 H]-thymidine incorporation or methylene blue assay, whereas insulin alone or in combination with other potential growth factors dose-dependently stimulated growth of these cells. The newly characterized GRP-preferring bombesin receptors on highly malignant human melanoma cells could initiate studies of growth effects on solid tumours or in vivo scanning using radiolabelled tracers. 相似文献
7.
Expression of human immunodeficiency virus type 1gag gene using genetically engineered herpes simplex virus type 1 recombinants 总被引:1,自引:0,他引:1
Angela Rösen-Wolff Karl Raab Lothar Zöller Gholamreza Darai Josef Eberle Friedrich Deinhardt 《Virus genes》1990,4(4):325-337
Infectious herpes simplex virus type 1 (HSV-1) recombinants were constructed by inserting the cDNA sequence of the human immunodeficiency virus type 1 (HIV-1)gag gene (from nucleotide position 675 [SacI] to 3859 [Asp 718] of the cDNA sequences of HIV-1 strain BH-10) within the DNA sequences of theBamHI DNA fragment B of the genome of an apathogenic HSV-1 strain HFEM. This HSV-1 strain possesses a 4.1-kbp deletion within theBamHI DNA fragment B between 0.762 and 0.789 map units of the viral genome, which allows the insertion of at least 4 kbp of foreign genetic material into this particular region. The DNA sequences of the immediate early promoter (IE4) of HSV-1 that were inserted upstream from thegag gene were used as a promoter. The screening of 205 virus stocks derived from individual plaques revealed that 46 recombinant viruses harbor HIV-1gag-specific DNA sequences. However, it was found that only six of the recombinant viruses are able to express thegag gene product of HIV-1. This indicates that the ratio of the positive recombination events is about 2.9%. 相似文献
8.
Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations. 总被引:10,自引:2,他引:10 下载免费PDF全文
In this communication, we examine the specificity of anti-herpes simplex virus (HSV) cytotoxic T lymphocytes (CTL). Serological studies of the two related HSV serotypes (HSV-1 and HSV-2) have revealed both type-specific and cross-reactive antigenic determinants in the viral envelope and on the surface of infected cells. By analysis of cytotoxicity of CTL, generated in vitro by restimulation of splenocytes from mice primed with one or the other HSV serotype, the recognition of both type-specific and cross-reactive determinants on infected target cells by anti-HSV CTL was detectable. Thus, effector cells generated by priming and restimulating with the same virus recognized both type-specific and cross-reactive determinants on target cells infected with the homologous virus, but only cross-reactive determinants on target cells infected with the heterologous HSV serotype. CTL generated by restimulation with the heterologous virus were capable of recognizing only the cross-reactive determinants on either HSV-1- or HSV-2-infected target cells. These results indicate that two subpopulations of CTL exist in a population of anti-HSV immune spleen cells--those which recognize type-specific determinants and those specific for cross-reactive antigenic determinants present on the surface of HSV infected cells. The type-specific subset of anti-HSV CTL was shown to recognize the gC glycoprotein of HSV-1 infected target cells. In addition to the gC glycoprotein, at least one other type-specific surface antigen was also recognized by anti-HSV CTL in addition to the cross-reactive determinants recognized by anti-HSV CTL. 相似文献
9.
Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. 总被引:2,自引:2,他引:2 下载免费PDF全文
W R Drobyski M Eberle D Majewski L A Baxter-Lowe 《Journal of clinical microbiology》1993,31(6):1515-1520
An oligotyping methodology was devised by using the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization in order to discriminate the A and B variants of human herpesvirus 6 (HHV-6). Comparative DNA sequence analysis of portions of the U1102 (variant A) and Z29 (variant B) genomes revealed polymorphic regions which allowed for the synthesis of variant-specific and consensus oligonucleotide probes. These probes were found to hybridize exclusively to their respective HHV-6 variants. This strategy was then further tested by evaluating 16 clinical isolates derived from patients undergoing bone marrow transplantation to determine the subtype prevalence of HHV-6 infection in these patients. All clinical isolates were documented to be of variant B, indicating that the majority of bone marrow transplantation patients may be preferentially infected with this HHV-6 subtype. This oligotyping strategy may be useful in defining the relative prevalence of HHV-6A and HHV-6B infections in patient populations potentially at risk for HHV-6 disease. 相似文献
10.
Comparative pathology of infections with baboon and African green monkey alpha-herpesviruses in mice
The comparative pathology of Herpesvirus papio 2 (HVP2) of baboons and SA8 virus of African green monkeys relative to that of herpes simplex virus (HSV1) of man was investigated in young adult mice inoculated intramuscularly and observed for 21 days. The 50% infectious dose (ID(50)) for HVP2 was approximately 10(2.0) plaque-forming units (PFU), while the ID(50) for HSV1 and SA8 was 10(2.5) and 10(3.8), respectively. There were marked differences in the ability of these three viruses to invade the central nervous system (CNS) and cause clinical neurological disease. HSV1 produced neurological signs in a few animals given 10(6)PFU, but SA8 did not. In contrast, HVP2 readily invaded the CNS and produced fatal disease with doses as low as 10(2)PFU. Two isolates of HVP2 tested had a 50% CNS disease dose (CNSD(50)) of 10(2.5) and 10(3.0)PFU and an LD(50) of 10(3.8) and 10(4.3)PFU, respectively. Histopathological examination of tissue from HVP2-infected mice revealed severe lesions of inflammation and necrosis in the central, peripheral and autonomic nervous systems, as well as of other tissues including skin, adrenal glands and the gastrointestinal tract. Viral antigens were detected immunohistochemically in lesions. This study showed that while both HVP2 and SA8 could infect mice, there were marked differences in the ability of these two closely related viruses to cause clinical disease and CNS lesions. This murine model may prove useful in the investigation of viral or host determinants responsible for the varying neurovirulence of these simian alpha-herpesviruses. 相似文献